AI assistant
Natco Pharma Ltd. — Call Transcript 2021
Aug 9, 2021
62741_rns_2021-08-09_6806f16a-3975-40d9-b5e8-15663c6ed4c4.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [416 x 43] intentionally omitted <==
August 7, 2021
Corporate Relationship Department M/s. BSE Ltd Dalal Street, For, Mumbai 400001
Manager – Listing M/s. National Stock Exchange of India Ltd “Exchange Plaza, Bandra Kurla Complex Bandra East, Mumbai 400051
Scrip Code: 524816
Scrip Code: NATCOPHARM
Dear Sir
Sub: - Q1 FY22 Financial Results Earnings Call
The Company will host an Earnings Call with Investors / Analysts at on Thursday, August 12, 2021, at 6:00 PM IST to disseminate Financial Results of the company for the Q1 FY22 ending June 30, 2021.
A Copy of the same is enclosed for your ready reference
Thanking you
Yours faithfully For NATCO Pharma Limited
ADINARAYANA MADINEEDI Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, o=Personal, 2.5.4.20=98307de121abc9bab67f3e00bc3fdead0597f7b7c44a25eaab89442f8748d254, postalCode=500017, st=TELANGANA, serialNumber=3da487f04b8912870dea3f277d9e87fc06da96e80b36d2beb1428dfe3f665de7, cn=ADINARAYANA MADINEEDI Date: 2021.08.09 10:33:51 +05'30'
M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)
Investec India invites you to Natco Pharma Q1 FY22 Earnings call
==> picture [129 x 59] intentionally omitted <==
Q1 FY22 Earnings Call Thursday, August 12, 2021 Diamond Pass Registration 6:00 pm IST Management Team Mr. Rajeev Nannapaneni Mr. Rajesh Chebiyam Vice Chairman & Chief Executive VP-Acquisitions, Institutional Officer Investor Management & Corporate Communications Dial-In Numbers Universal Dial-In International Toll Free (+91 22 6280 1245) / (+91 22 7115 8146) Hong Kong (800964448) Singapore (8001012045) UK (08081011573) USA (18667462133) For further information please contact: Anshuman Gupta (+9122 6849 7440 ) Swapna Bhandarkar (+9122 6849 7472) [email protected] [email protected]
==> picture [113 x 24] intentionally omitted <==
Investec Bank plc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Registered in England and Wales (No. 489604). Registered office at 30 Gresham St, London EC2V 7QP.